Dihydroergotamine Mesylate Spray Articles
Valeant's 2nd-qtr 2007 income stays constant
13 August 2007
News In Brief
11 December 1997
Showing 1-4 of 4 articles
- 1
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
